What is the primary impact of the Health Reform Law on HCA Healthcare?

The Health Reform Law presents a dual impact. It may increase patient volume due to expanded insurance coverage, potentially boosting revenue. However, it also includes significant reductions in Medicare spending growth and Medicare/Medicaid DSH payments, which could negatively affect a substantial portion of HCA's revenue derived from these government programs.

How is HCA Healthcare managing the increasing risk of uncollectible patient accounts?

HCA Healthcare acknowledges the growing risk associated with uninsured patients and the collectibility of patient responsibility amounts (deductibles and co-payments). The company bases its provision for doubtful accounts on historical data, economic conditions, and collection indicators. The allowance for doubtful accounts represented approximately 94% of the patient due accounts receivable balance as of March 31, 2010.

What is the status of HCA Healthcare's Corporate Integrity Agreement (CIA)?

HCA Healthcare's eight-year CIA with the Office of Inspector General (OIG) expired on January 24, 2009. In April 2010, the company received notice that its final report submitted under the CIA was accepted, relieving it of future obligations. However, the government could still review the adequacy of its reporting and resolution of reported issues.

Are there any significant ongoing tax disputes that could affect HCA?

Yes, HCA Healthcare is contesting certain claimed deficiencies and adjustments proposed by the IRS for its 2003-2004 federal income tax returns, primarily related to the timing of revenue recognition and the calculation of the tax allowance for doubtful accounts. Audits for subsequent years are also ongoing or anticipated. While management believes the final resolution will not be materially adverse, there is a risk that payments due could exceed recorded estimates.

HCA 10-Q Quarterly Report Q1 FY2010 — Revenue, Net Income, EPS

Summary

This 10-Q filing for HCA Healthcare, Inc. for the period ending March 30, 2010, highlights the company's operational landscape dominated by significant regulatory and competitive pressures. A key focus for investors is the ongoing impact of the recently enacted Health Reform Law, which introduces both potential opportunities through expanded insurance coverage and significant risks related to Medicare and Medicaid reimbursement reductions. The company also faces intensified competition, increased patient financial responsibility, and ongoing government investigations and litigation. While management expresses confidence in its controls and procedures, the complexity and uncertainty surrounding the healthcare reform and its implications on revenue streams and operational costs warrant careful investor consideration.

Financial Highlights

22 data points

Beta

Revenue

$6.98B

Net Income

$388.00M

0.1% Net Margin

EPS (Diluted)

$0.89

Cash & Equivalents

$388.00M

Free Cash Flow

$645.00M

Financial Statements

Beta

Revenue	$6.98B
Interest Expense	$516.00M
Net Income	$388.00M
EPS (Basic)	$0.91
EPS (Diluted)	$0.89
Shares Outstanding (Basic)	426.35M
Shares Outstanding (Diluted)	435.68M

Key Highlights

1The company is operating under the significant influence of the recently enacted Health Reform Law, which has a complex and uncertain impact on future revenues, particularly concerning Medicare and Medicaid reimbursement changes.
2HCA Healthcare faces intensified competition from other hospitals, specialty facilities, and ambulatory surgery centers, potentially impacting patient volumes and profit margins.
3There's a growing concern regarding the collectibility of patient accounts receivable, with an increasing proportion of uninsured patients and a rising provision for doubtful accounts.
4A substantial portion of HCA's revenue (approximately 40% in 2009) is derived from government programs (Medicare and Medicaid), making the company vulnerable to changes in reimbursement rates and program funding, including reductions outlined in the Health Reform Law.
5The company has successfully concluded its eight-year Corporate Integrity Agreement (CIA) with the OIG, with its final report accepted in April 2010, though potential future government scrutiny remains.
6HCA Healthcare is actively involved in various legal proceedings and government investigations, typical for the highly regulated healthcare industry, which could materially affect its financial position.
7The company is contesting certain IRS claims related to tax returns from 2003-2006, concerning revenue recognition and the tax allowance for doubtful accounts, with management believing final resolution will not be materially adverse, but acknowledging the risk of exceeding recorded estimates.

HCA Healthcare, Inc. Quarterly Report for Q1 Ended Mar 31, 2010

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions